See more : PT Dharma Polimetal Tbk (DRMA.JK) Income Statement Analysis – Financial Results
Complete financial analysis of Redwood Scientific Technologies, Inc. (RSCI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Redwood Scientific Technologies, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Enzolytics Inc. (ENZC) Income Statement Analysis – Financial Results
- Golden Falcon Acquisition Corp. (GFX-WT) Income Statement Analysis – Financial Results
- Volcan Holdings, Inc. (VOHO) Income Statement Analysis – Financial Results
- NITCO Limited (NITCO.BO) Income Statement Analysis – Financial Results
- Rexford Industrial Realty, Inc. (REXR-PC) Income Statement Analysis – Financial Results
Redwood Scientific Technologies, Inc. (RSCI)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.redwoodscientific.co
About Redwood Scientific Technologies, Inc.
Redwood Scientific Technologies, Inc. develops and markets over-the-counter FDA registered drugs through oral strip delivery technology. The company is based in Claremont, California.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.71M | 5.26M |
Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.03M | 2.22M |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 5.68M | 3.04M |
Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 73.63% | 57.74% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 143.71K | 0.00 | 42.74K | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 3.48M | 143.71K | 0.00 | 42.74K | 0.00 | 0.00 | 5.37M | 3.56M |
Other Expenses | 0.00 | 0.00 | 0.00 | -164.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 3.48M | 143.71K | 0.00 | 49.14K | 0.00 | 0.00 | 5.37M | 3.56M |
Cost & Expenses | 3.48M | 143.71K | 0.00 | 49.14K | 0.00 | 0.00 | 7.40M | 5.78M |
Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 141.67K | 21.94K |
Depreciation & Amortization | 167.90K | 228.49K | 236.56K | 206.30K | 171.86K | 161.14K | 52.52K | 22.82K |
EBITDA | -3.48M | -143.71K | 0.00 | -49.14K | 0.00 | 0.00 | 235.90K | -955.65K |
EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.99% | -9.94% |
Operating Income | -3.48M | -143.71K | 0.00 | -42.74K | 0.00 | 0.00 | 307.33K | -522.59K |
Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 3.99% | -9.94% |
Total Other Income/Expenses | -4.00 | 0.00 | 0.00 | -6.56K | 0.00 | 0.00 | -213.10K | -455.00K |
Income Before Tax | -3.48M | -143.71K | 0.00 | -49.30K | 0.00 | 0.00 | 94.23K | -977.60K |
Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.22% | -18.60% |
Income Tax Expense | -167.90K | -228.49K | 0.00 | 6.40K | 0.00 | 0.00 | 700.00 | 36.84K |
Net Income | -3.48M | -143.71K | 0.00 | -49.30K | 0.00 | 0.00 | 93.53K | -1.01M |
Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1.21% | -19.30% |
EPS | -0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.55 | -6.02 |
EPS Diluted | -0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.55 | -6.02 |
Weighted Avg Shares Out | 193.43M | 177.93M | 177.93M | 177.93M | 0.00 | 0.00 | 168.63K | 168.63K |
Weighted Avg Shares Out (Dil) | 193.43M | 177.93M | 177.93M | 177.93M | 0.00 | 0.00 | 168.63K | 168.63K |
Redwood Scientific Technologies Inc. Announces Finalization of TBX VAPE FREE Product Flavors
Redwood Scientific Technologies Inc. (OTC: RSCI) ("Redwood" or "the Company"), a pharmaceutical company, today announced a strategic shift in its product development priorities
Company Initiates Plans to Build Oral Thin Film Manufacturing in the USA for Its Stop Smoking and Stop Vaping Products
Redwood Scientific Enters into Agreement with Jeeva Clinical Trials to Launch Clinical Effectiveness Study of its TBX-Free Oral Strips for Smoking and E-cigarette Cessation
Redwood Scientific Technologies Inc. (RSCI.OTC.PK) Announces Successful S1 Registration Filing and Provides Updates on TBX FREE Clinical Trial Progress
Source: https://incomestatements.info
Category: Stock Reports